151 related articles for article (PubMed ID: 38033415)
1. Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary.
Ben Ltaief S; Ghalleb M; Chabchoub A; Slimen M; Hadj Kacem L; Zenzeri Y; Chargui R; Dhieb T
Case Rep Oncol; 2023; 16(1):1494-1499. PubMed ID: 38033415
[TBL] [Abstract][Full Text] [Related]
2. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
[TBL] [Abstract][Full Text] [Related]
3. Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
Gouy S; Saidani M; Maulard A; Faron M; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Gynecol Oncol Rep; 2017 Nov; 22():52-54. PubMed ID: 29022007
[TBL] [Abstract][Full Text] [Related]
4. Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.
Lin W; Cao D; Shi X; You Y; Yang J; Shen K
Front Oncol; 2022; 12():856818. PubMed ID: 35860580
[TBL] [Abstract][Full Text] [Related]
5. Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types.
Gouy S; Saidani M; Maulard A; Faron M; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Gynecol Oncol Rep; 2017 Nov; 22():21-25. PubMed ID: 28971140
[TBL] [Abstract][Full Text] [Related]
6. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
7. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
8. Fertility-Sparing Surgery and Adjuvant Chemotherapy with Trastuzumab Result in Complete Remission in a Young Woman with Rare Primary Mucinous Ovarian Cancer due to ERBB2 Co-amplification with CDK12 and Chromosome 11q13.3 Amplicon: A Case Report and Literature Review.
Gao L; Huang T; Zhong L; Peng L; Huang Z; Lu Y
Reprod Sci; 2024 Jun; 31(6):1626-1631. PubMed ID: 38216775
[TBL] [Abstract][Full Text] [Related]
9. Safety of fertility sparing management in invasive mucinous ovarian carcinoma.
Kim SR; Madariaga A; Hogen L; Vicus D; Covens A; Parra-Herran C; Lheureux S; Gien LT
Gynecol Oncol; 2023 Jul; 174():129-132. PubMed ID: 37182433
[TBL] [Abstract][Full Text] [Related]
10. Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary.
Huin M; Lorenzini J; Arbion F; Carcopino X; Touboul C; Dabi Y; Kerbage Y; Costaz H; Lecointre L; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Mimoun C; Bendifallah S; Gauthier T; Body G; Ouldamer L;
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294441
[No Abstract] [Full Text] [Related]
11. A patient with a mucinous borderline ovarian tumor after fertility-sparing surgery in whom puncture fluid cytology on oocyte retrieval led to a diagnosis of recurrence.
Yoshiba T; Takei Y; Manaka Y; Suzuki T; Fujiwara H
J Obstet Gynaecol Res; 2022 Oct; 48(10):2635-2639. PubMed ID: 35871537
[TBL] [Abstract][Full Text] [Related]
12. [Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Uzan C; Courbiere B; Chabbert-Buffet N
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):180-186. PubMed ID: 30704956
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Int J Gynecol Cancer; 2018 Mar; 28(3):493-499. PubMed ID: 29466254
[TBL] [Abstract][Full Text] [Related]
14. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
15. Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases.
Muyldermans K; Moerman P; Amant F; Leunen K; Neven P; Vergote I
Eur J Cancer; 2013 May; 49(7):1600-8. PubMed ID: 23321546
[TBL] [Abstract][Full Text] [Related]
16. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
17. Primary mucinous ovarian cancer: options for surgery and chemotherapy.
Kurnit KC; Frumovitz M
Int J Gynecol Cancer; 2022 Oct; ():. PubMed ID: 36229081
[TBL] [Abstract][Full Text] [Related]
18. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
19. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
[TBL] [Abstract][Full Text] [Related]
20. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.
Lee KR; Scully RE
Am J Surg Pathol; 2000 Nov; 24(11):1447-64. PubMed ID: 11075847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
